Suspecting abuse-resistant Oxycontin, buyer kills dealer

In a drug deal gone bad in Boston, the buyer concluded that his source was selling the newer Oxycontin, reformulated to prevent abuse. It wouldn't burn, so it couldn't be smoked. Police suspect that the test failure cost the drug dealer his life. They also suspect that pills were not the reformulated Oxycontin, but rather a fake or a different drug. Article

 

Suggested Articles

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.

Korean CDMO Samsung Biologics is expanding and China API maker WuXi STA opened a 30,000-square-foot oligonucleotide manufacturing facility.